Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance. | Cells | 2023 | 36831294 | PubTator, text mining | PubMed |
| In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines. | Cells | 2023 | 36831263 | PubTator, text mining | PubMed |
| An Insight on Functioning Pancreatic Neuroendocrine Neoplasms. | Biomedicines | 2023 | 36830839 | PubTator, text mining | PubMed |
| Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. | Biology (Basel) | 2023 | 36829492 | PubTator, text mining | PubMed |
| Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN). | Curr Oncol Rep | 2023 | 36826704 | PubTator, text mining | PubMed |
| PIK3R1, HRAS and AR Gene Alterations Associated with Sclerosing Polycystic Adenoma of the Parotid Gland. | Curr Issues Mol Biol | 2023 | 36826006 | PubTator, text mining | PubMed |
| Bacteria and macrophages in the tumor microenvironment. | Front Microbiol | 2023 | 36825088 | PubTator, text mining | PubMed |
| Treatment of extranodal NK/T-cell lymphoma: From past to future. | Front Immunol | 2023 | 36825002 | PubTator, text mining | PubMed |
| CtDNA's prognostic value in patients with early-stage colorectal cancer after surgery: A meta-analysis and systematic review. | Medicine (Baltimore) | 2023 | 36820557 | PubTator, text mining | PubMed |
| Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. | J Pharm Anal | 2023 | 36820078 | PubTator, text mining | PubMed |
| Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications. | Noncoding RNA Res | 2023 | 36818396 | PubTator, text mining | PubMed |
| The role of immunotherapy in non-clear cell renal cell carcinoma. | Front Oncol | 2023 | 36816976 | PubTator, text mining | PubMed |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. | Hum Genomics | 2023 | 36814285 | PubTator, text mining | PubMed |
| FixItFelix: improving genomic analysis by fixing reference errors. | Genome Biol | 2023 | 36810122 | PubTator, text mining | PubMed |
Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential. | Diagn Pathol | 2023 | 36810118 | PubTator, text mining | PubMed |
| The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. | Eur J Med Res | 2023 | 36805828 | PubTator, text mining | PubMed |
| Investigation of autism-related transcription factors underlying sex differences in the effects of bisphenol A on transcriptome profiles and synaptogenesis in the offspring hippocampus. | Biol Sex Differ | 2023 | 36803626 | PubTator, text mining | PubMed |
| Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. | Cell Stem Cell | 2023 | 36803553 | PubTator, text mining | PubMed |
Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review. | Front Immunol | 2023 | 36798130 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=39